GLI1 and leukemia: Recent studies could demonstrate a role of deregulated HH signaling and GLI transcription factors in the maintenance, function and drug resistance of myeloid LCSs whose leukemia promoting capacities could get effectively diminished by HH pathway inhibition [53–55].